Q4 2018 EPS Estimates for UnitedHealth Group Inc (UNH) Cut by Oppenheimer

UnitedHealth Group Inc (NYSE:UNH) – Research analysts at Oppenheimer dropped their Q4 2018 earnings estimates for shares of UnitedHealth Group in a research note issued to investors on Tuesday, October 16th. Oppenheimer analyst M. Wiederhorn now forecasts that the healthcare conglomerate will earn $3.19 per share for the quarter, down from their previous estimate of $3.24. Oppenheimer has a “Outperform” rating and a $295.00 price target on the stock. Oppenheimer also issued estimates for UnitedHealth Group’s Q2 2019 earnings at $3.56 EPS.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.30 by $0.11. The business had revenue of $56.56 billion for the quarter, compared to analysts’ expectations of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The firm’s quarterly revenue was up 12.4% compared to the same quarter last year. During the same period last year, the firm posted $2.66 earnings per share.

UNH has been the topic of a number of other reports. Jefferies Financial Group lifted their price objective on shares of UnitedHealth Group from $270.00 to $311.00 and gave the company a “buy” rating in a research note on Wednesday, October 3rd. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $278.00 to $305.00 and gave the company an “overweight” rating in a research note on Wednesday, September 5th. Argus lifted their price objective on shares of UnitedHealth Group to $285.00 and gave the company a “buy” rating in a research note on Thursday. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 18th. Finally, ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, October 2nd. One investment analyst has rated the stock with a hold rating, twenty-three have given a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $289.41.

Shares of NYSE:UNH opened at $265.30 on Friday. The company has a market capitalization of $257.27 billion, a P/E ratio of 26.52, a PEG ratio of 1.58 and a beta of 0.73. The company has a current ratio of 0.69, a quick ratio of 0.75 and a debt-to-equity ratio of 0.61. UnitedHealth Group has a 1 year low of $203.69 and a 1 year high of $272.81.

In other news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction on Wednesday, August 1st. The shares were sold at an average price of $254.79, for a total transaction of $3,821,850.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP D Ellen Wilson sold 15,393 shares of UnitedHealth Group stock in a transaction on Friday, August 24th. The stock was sold at an average price of $264.29, for a total transaction of $4,068,215.97. Following the transaction, the executive vice president now owns 66,402 shares in the company, valued at approximately $17,549,384.58. The disclosure for this sale can be found here. Insiders sold 94,568 shares of company stock worth $24,950,027 in the last 90 days. Company insiders own 0.87% of the company’s stock.

Several large investors have recently modified their holdings of the company. DeDora Capital Inc. raised its stake in UnitedHealth Group by 60.2% during the third quarter. DeDora Capital Inc. now owns 6,672 shares of the healthcare conglomerate’s stock worth $1,775,000 after buying an additional 2,506 shares during the last quarter. Abner Herrman & Brock LLC raised its stake in UnitedHealth Group by 7.1% during the third quarter. Abner Herrman & Brock LLC now owns 40,354 shares of the healthcare conglomerate’s stock worth $10,736,000 after buying an additional 2,680 shares during the last quarter. West Coast Financial LLC bought a new position in UnitedHealth Group during the third quarter worth $500,000. Brand Asset Management Group Inc. raised its stake in UnitedHealth Group by 95.8% during the third quarter. Brand Asset Management Group Inc. now owns 6,542 shares of the healthcare conglomerate’s stock worth $1,741,000 after buying an additional 3,200 shares during the last quarter. Finally, Palisade Asset Management LLC raised its stake in UnitedHealth Group by 14.8% during the third quarter. Palisade Asset Management LLC now owns 79,845 shares of the healthcare conglomerate’s stock worth $21,242,000 after buying an additional 10,302 shares during the last quarter. Institutional investors own 85.42% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: What is an Initial Public Offering (IPO)?

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply